Yuqian Liao
Nanchang, 330006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The different sequences of CDK4/6 inhibitor and mTOR inhibitor in HR+/HER2-advanced breast cancer: A multicenter real-world study.
Journal: Heliyon
Published: July 03, 2024
The Prognostic Role of HuR Varies Between Different Subtypes of Breast Cancer Patients: Data Mining and Retrospective Analysis.
Journal: Breast cancer (Dove Medical Press)
Published: November 09, 2022
RPL35A is a key promotor involved in the development and progression of gastric cancer.
Journal: Cancer cell international
Published: October 27, 2020
Polymorphisms in PARP1 predict disease-free survival of triple-negative breast cancer patients treated with anthracycline/taxane based adjuvant chemotherapy.
Journal: Scientific reports
Published: October 15, 2019
Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy.
Journal: Cancer management and research
Published: October 06, 2018
Genetic variants in miRNA machinery genes associated with clinicopathological characteristics and outcomes of gastric cancer patients.
Journal: The International journal of biological markers
Published: April 24, 2018
DROSHA rs10719 T>C is associated with lymph node metastasis and clinical stage of gastric cancer patients.
Journal: International journal of clinical and experimental pathology
Published: September 20, 2016
Acceptable but limited efficacy of capecitabine-based doublets in the first-line treatment of metastatic triple-negative breast cancer: a pilot study.
Journal: Chemotherapy
Published: May 13, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026